FDA approves antibacterial drug for UTIs

Listen
Text
  • Small
  • Medium
  • Large

The Food and Drug Administration on Tuesday approved Rempex Pharmaceuticals' antibacterial drug Vabomere.

Here are three things to know.

  1. The drug is approved to treat adults with complicated urinary tract infections, including a type of kidney infection called pyelonephritis.

  1. Vabomere is an intravenous combination drug made up of meropenem — an antibiotic — and vaborbactam, which inhibits certain resistance mechanisms used by bacteria.

  1. Rempex Pharmaceuticals' expects Vabomere to hit the market in the fourth quarter of this year.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.